Its referring to oral infection, so one would think you'd stay away from the Japanese bbbj provider, no?Scary. Stay away from Japanese sex workers?
Not that there is much risk of finding an actual Japanese sp in Vancouver, in spite of all the advertising to the contrary.H041, first found in a the pharynx of a Japanese sex worker, is 4- to 8-fold more resistant to ceftriaxone — the only form of cephalosporin used to treat that type of gonorrhea in the throat — than any strain ever found.
The samples are very small, but it speaks to how the medical community are so on top of it, thank god. Nevertheless, they predicted this would happen and they consider it an important and significant development - and brings back old questions about the cycle of antibiotics and virus prevention. They emphasized in the article that they are watching and hoping that it does not spread. Three possible nightmare scenarios: 1) it spreads before they find an antibiotic, 2) continued cycle "creates" a strain that mutates so quickly they can't create an antibiotic fast enough, 3) that cycle "creates" a mutation that becomes something deadly like HIV.Before everyone gets too excited here are some numbers from the article and note the info refers to the US and Japan.
"1.4 percent of patient samples showed growing ability to defeat cefixime in 2010 compared to just .2 percent in 2000. Resistance to ceftiaxone grew from .1 percent to .3 percent during the same period.
Then Sunday, a Japanese-European team presenting data at the International Society for Sexually Transmitted Disease Research meeting in Quebec City, Canada, publicly announced the discovery of a new strain of gonorrhea, H041, that displays a strong resistance to ceftriaxone."
There's a price to fucking around, you know.
Until recently, research and development (R&D) efforts have provided new drugs in time to treat bacteria that became resistant to older antibiotics. That is no longer the case.The potential crisis at hand is the result of a marked decrease in industry R&D, and the increasing prevalence of resistant bacteria. Infectious disease physicians are alarmed by the prospect that effective antibiotics may not be available to treat seriously ill patients in the near future.
As bacterial antibiotic resistance continues to exhaust our supply of effective antibiotics, a global public health disaster appears likely. Poor financial investment in antibiotic research has exacerbated the situation. A call to arms raised by several prestigious scientific organisations a few years ago rallied the scientific community, and now the scope of antibacterial research has broadened considerably.
The pipeline of new antibiotics is drying up.[citation needed]Major pharmaceutical companies are losing interest in the antibiotics market because these drugs may not be as profitable as drugs that treat chronic (long-term) conditions and lifestyle issues.
http://en.wikipedia.org/wiki/Antibiotic_resistance